Skip to main content
Clinical Trials/NCT01865123
NCT01865123CompletedNot Applicable

A Randomized Controlled Trial of Meditation Compared to Exposure Therapy and Education Control on PTSD in Veterans

United States Department of Defense1 site in 1 country200 target enrollmentStarted: June 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
200
Locations
1
Primary Endpoint
Clinically Administered PTSD Scale (CAPS)

Study Overview

Brief Summary

The purpose of this study is to compare the effectiveness of the Transcendental Meditation (TM) program to the more standard Cognitive Behavioral Therapy with Prolonged Exposure (CBT-PE) in treating posttraumatic stress disorder (PTSD) in war Veterans over a three month treatment period.

Detailed Description

Posttraumatic stress disorder (PTSD) is a common and debilitating anxiety condition that affects up to 20% of war Veterans. PTSD is often a chronic problem for Veterans, affecting reintegration into society, family and marital relationships, sleep, employment stability, substance abuse rates, and risk for depression and suicide, among other areas. Although several effective therapies exist to treat PTSD, research shows that up to half of patients completing these treatments continue to have elevated symptoms indicating the important need for developing additional treatment options.

In the current trial, we propose to test one such new treatment, specifically a meditation practice known as Transcendental Meditation. The Transcendental Meditation (TM) program will be compared to one of the best and most standard of PTSD therapies (Prolonged Exposure therapy), and a educational control group. This study will recruit 210 War Veterans clinically diagnosed with PTSD from the San Diego VA Healthcare System over a 4 year study period.

The intervention period will be 3 months. Study participants will be randomized equally to one of three study groups, either

  1. Transcendental Meditation (TM) or
  2. Cognitive Behavioral Therapy with Prolonged Exposure (CBT-PE) or
  3. Educational control group.

The primary outcome will be scores on the Clinically Administered PTSD Scale (CAPS).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Investigator)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Current medical diagnosis of PTSD
  • A symptom severity score of 45 or higher on the Clinically Administered PTSD Scale (CAPS)
  • Three or more months since service-related trauma
  • If being treated with psychoactive medication, a stable regimen (no change in drugs or dose) for at least 2 months before enrollment
  • Age: 18 years or older
  • Language: English literate -

Exclusion Criteria

  • Current unstable or uncontrolled psychotic symptoms, mania or bipolar disorder
  • Current suicidal or homicidal ideation
  • Moderate or greater cognitive impairment indicated by chart diagnosis or observable cognitive difficulties
  • Having received Prolonged Exposure therapy or having been instructed in Transcendental Meditation.

Arms & Interventions

Transcendental Meditation

Experimental

TM is a simple, natural, effortless mental technique practiced with eyes closed sitting for 20 minutes twice a day. This allows the practitioner to experience lesser excited levels of the mind and correspondingly greater degrees of physical relaxation. TM is a traditional meditation technique that has its origin in the ancient Vedic tradition of India.

Intervention: Transcendental Meditation (Behavioral)

Prolonged Exposure

Active Comparator

Prolonged Exposure (PE) is a specialized type of Cognitive Behavorial Therapy employing a manualized, trauma-focused behavioral treatment for PTSD and is based on exposure principles and emotional processing theory.

Intervention: Prolonged Exposure (Behavioral)

Educational Control

Placebo Comparator

Didactic based instructional classes will provide health education which will include the benefits of proper diet, exercise, and reducing smoking and alcohol. No stress management techniques will be taught.

Intervention: Educational control (Behavioral)

Outcomes

Primary Outcomes

Clinically Administered PTSD Scale (CAPS)

Time Frame: 3 months

This scale is currently the gold standard for assessing the severity of post-traumatic stress disorder (PTSD) using a face-to-face interview with the patient and a professionally trained medical/psychiatric administrator.

Secondary Outcomes

  • Self-Report Symptoms of PTSD(3 months)

Investigators

Sponsor Class
Fed
Responsible Party
Principal Investigator
Principal Investigator

Sanford Nidich, Ed.D.

Associate Director

Maharishi International University

Study Sites (1)

Loading locations...

Similar Trials